Mosaic Trisomy 12: Prenatal Diagnosis at Amniocentesis and Molecular Genetic Analysis on Fetal Tissues.
Paola BonasoniGabriele TonniGiuseppina ComitiniVeronica BarbieriMonia RinaldiniMaria MarinelliPublished in: Fetal and pediatric pathology (2020)
Background: Mosaic trisomy 12 is a genetic condition with few cases diagnosed prenatally and postnatally. Phenotypic variability is wide ranging from normal patients to severe congenital anomalies. Case report: A 35-year-old woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age. Prenatal ultrasound was negative. Cultured amniocytes revealed a karyotype of 47,XX,+12/46,XX. Parents opted for termination of pregnancy at 22 weeks. Postmortem revealed dysmorphic face; hands with broad thumbs and incomplete transverse palmar creases; partial anomalous pulmonary venous return, intestinal malrotation, and bicornuate uterus. Histologically, no anomalies were identified. Cytogenetic analyses on fetal tissues detected mosaic trisomy 12 in thymus, lung, brain, kidney, placenta, and cord blood. Discussion/Conclusion: We report a new case of mosaic trisomy 12 with non-lethal morphological findings not previously described. Although prenatal ultrasound may be negative, genetic counseling should consider minor abnormalities and widespread presence of trisomic cell lines in various internal organs.
Keyphrases
- cord blood
- case report
- end stage renal disease
- magnetic resonance imaging
- pregnant women
- gestational age
- gene expression
- chronic kidney disease
- ejection fraction
- newly diagnosed
- single cell
- genome wide
- pulmonary hypertension
- birth weight
- preterm infants
- early onset
- copy number
- white matter
- prognostic factors
- endothelial cells
- resting state
- dna methylation
- functional connectivity
- smoking cessation
- body mass index
- human immunodeficiency virus
- brain injury
- antiretroviral therapy
- blood brain barrier